List of works - David Diemert

A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries

scientific article published on 23 January 2017

A history of hookworm vaccine development

scientific article published in November 2011

Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine

scientific article

Advancing the Development of a Human Schistosomiasis Vaccine

scientific article published on 16 November 2018

Age patterns in undernutrition and helminth infection in a rural area of Brazil: associations with ascariasis and hookworm.

scientific article published on 25 February 2008

An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases

scientific article

Assessment of the dissemination of COVID-19 articles across social media- An Altmetrics and PlumX Study

scientific article published on 12 December 2020

Can schistosomiasis really be consigned to history without a vaccine?

scientific article published on 7 May 2008

Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination

scientific article published on December 2008

Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population

scientific article

Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development.

scientific article published on 19 April 2018

Correction: Microproteinuria during Opisthorchis viverrini Infection: A Biomarker for Advanced Renal and Hepatobiliary Pathologies from Chronic Opisthorchiasis

scientific article published on 23 August 2013

Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

scientific article published on 17 August 2020

Debate: Letter to the Editors

scientific article published on 01 March 2007

Developing vaccines to combat hookworm infection and intestinal schistosomiasis

scientific article

Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.

scientific article published on August 2012

Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths

scientific article published on 26 May 2012

Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil

scientific article (publication date: 2010)

Hookworm infection

article

Hookworm, Ascaris lumbricoides infection and polyparasitism associated with poor cognitive performance in Brazilian schoolchildren

scientific article

Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians

scientific article

Impact of gender on the decision to participate in a clinical trial: a cross-sectional study ⬇️

scientific article

Improving the understanding of schistosomiasis among adolescents in endemic areas in Brazil: A comparison of educational methods

scientific article published on 26 April 2016

Lessons along the Critical Path: Developing Vaccines against Human Helminths

scientific article published on 28 July 2018

Malaria "epidemic" in Quebec: diagnosis and response to imported malaria

scientific article

Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis

scientific article

Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting

scientific article

Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines

scientific article published on July 2012

Necator americanus and helminth co-infections: further down-modulation of hookworm-specific type 1 immune responses

scientific article published on 6 September 2011

New technologies for the control of human hookworm infection

scientific article

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

scientific article

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

scientific article published in May 2005

Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design

scholarly article

Potency testing for the experimental Na-GST-1 hookworm vaccine

scientific article published on October 2010

Prevention and self-treatment of traveler's diarrhea

scientific article

Prevention and self-treatment of travelers' diarrhea

scientific article

Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults

scientific article

Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community

scientific article published on 08 August 2011

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial

scientific article

Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial

scientific article published on 11 September 2020

Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

scientific article

Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths

scientific article

Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven bySchistosoma mansoniinfection in humans

scientific article published on 15 March 2013

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

scientific article (publication date: 6 May 2006)

Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.

scientific article published in January 2001

Stage-specific immune responses in human Necator americanus infection.

scientific article

The Global Economic and Health Burden of Human Hookworm Infection

scientific article

The Human Hookworm Vaccine

scientific article published on April 2013

The Right Tool for the Job: Detection of Soil-Transmitted Helminths in Areas Co-endemic for Other Helminths

scientific article

Update on prevention and treatment of intestinal helminth infections

scientific article published on March 2015

Vaccination induces HIV broadly neutralizing antibody precursors in humans ⬇️

journal article published in 2022

Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity.

scientific article published in December 2007

List of works by David Diemert

A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries

A history of hookworm vaccine development

Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine

Advancing the Development of a Human Schistosomiasis Vaccine

Age patterns in undernutrition and helminth infection in a rural area of Brazil: associations with ascariasis and hookworm.

An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases

Assessment of the dissemination of COVID-19 articles across social media- An Altmetrics and PlumX Study

Can schistosomiasis really be consigned to history without a vaccine?

Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination

Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population

Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development.

Correction: Microproteinuria during Opisthorchis viverrini Infection: A Biomarker for Advanced Renal and Hepatobiliary Pathologies from Chronic Opisthorchiasis

Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

Debate: Letter to the Editors

Developing vaccines to combat hookworm infection and intestinal schistosomiasis

Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.

Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths

Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil

Hookworm infection

Hookworm, Ascaris lumbricoides infection and polyparasitism associated with poor cognitive performance in Brazilian schoolchildren

Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians

Impact of gender on the decision to participate in a clinical trial: a cross-sectional study ⬇️

Improving the understanding of schistosomiasis among adolescents in endemic areas in Brazil: A comparison of educational methods

Lessons along the Critical Path: Developing Vaccines against Human Helminths

Malaria "epidemic" in Quebec: diagnosis and response to imported malaria

Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis

Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting

Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines

Necator americanus and helminth co-infections: further down-modulation of hookworm-specific type 1 immune responses

New technologies for the control of human hookworm infection

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design

Potency testing for the experimental Na-GST-1 hookworm vaccine

Prevention and self-treatment of traveler's diarrhea

Prevention and self-treatment of travelers' diarrhea

Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults

Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial

Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial

Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths

Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven bySchistosoma mansoniinfection in humans

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.

Stage-specific immune responses in human Necator americanus infection.

The Global Economic and Health Burden of Human Hookworm Infection

The Human Hookworm Vaccine

The Right Tool for the Job: Detection of Soil-Transmitted Helminths in Areas Co-endemic for Other Helminths

Update on prevention and treatment of intestinal helminth infections

Vaccination induces HIV broadly neutralizing antibody precursors in humans ⬇️

Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity.